Latest Breaking News On - Biotech trading down - Page 2 : comparemela.com

Brokerages Set Legend Biotech Co (NASDAQ:LEGN) PT at $82 64

Brokerages Set Legend Biotech Co (NASDAQ:LEGN) PT at $82 64
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond jamesFinancial services group incRoyal bankLegend biotech coBarometer capital management incBluepath capital managementChina universal asset management coLegend biotech corporationLegend biotech company profileLegend biotechGet free reportBiotech trading downPath capital managementServices groupCapital management

Krystal Biotech (NASDAQ:KRYS) Announces Quarterly Earnings Results

Krystal Biotech (NASDAQ:KRYS) Announces Quarterly Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKathryn romanoSuma krishnanStifel nicolausKrystal biotech company profileKrystal biotech incSecurities exchange commissionKrystal biotechGet free reportBiotech trading downExchange commissionKrystal biotech daily

Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright

Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSuma krishnanKathryn romanoWilliam blairStifel nicolausQuest partnersChina universal asset management coInvestment partnersKrystal biotech incKrystal biotech company profileCapstone investment advisorsSecurities exchange commissionKrystal biotechGet free reportBiotech trading downExchange commission

Moleculin Biotech (NASDAQ:MBRX) Earns Sell Rating from Analysts at StockNews com

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. A number of other brokerages have also issued reports on MBRX. Maxim Group dropped their price target on shares of Moleculin Biotech from $45.00 to $20.00 […]

Roth mkmMaxim groupSecurities exchange commissionAtticus wealth managementMoleculin biotech incMoleculin biotechFree reportBiotech trading downWealth managementGet free reportMoleculin biotech daily

Krystal Biotech, Inc (NASDAQ:KRYS) Given Consensus Recommendation of Buy by Brokerages

Krystal Biotech, Inc (NASDAQ:KRYS) Given Consensus Recommendation of Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausKathryn romanoSuma krishnanWilliam blairMitsubishi ufjDeutsche bankKokusai asset management coCommonwealth equity servicesPrincipal financial group incKrystal biotech incKrystal biotechGet free reportBiotech trading downEquity servicesFinancial group